CN Stock MarketDetailed Quotes
301093 Jiangsu Hualan New Pharmaceutical Material
- 23.05
- +0.10+0.44%
Market Closed Dec 27 15:00 CST
2.93BMarket Cap36.24P/E (TTM)
23.21High22.83Low10.59KlotVolume23.21Open22.95Pre Close24.35MTurnover1.20%Turnover Ratio24.84P/E (Static)127.08MShares31.9452wk High1.34P/B2.04BFloat Cap17.1252wk Low27.54Limit Up88.29MShs Float56.28Historical High18.36Limit Down1.66%Amplitude17.12Historical Low0.60Dividend TTM23.00Avg Price5.57KlotAsk2.60%Div YieldTTM100Lot Size4.93KlotBid
Jiangsu Hualan New Pharmaceutical Material Key Stats
EPS
According to the latest financial report of Jiangsu Hualan New Pharmaceutical Material, the latest earnings per share (TTM) for the company is 0.41. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Jiangsu Hualan New Pharmaceutical Material's latest financial report to see how much their book value per share (BVPS) is currently at 17.23.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Jiangsu Hualan New Pharmaceutical Material shows that the company's current ratio is 10.55, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Jiangsu Hualan New Pharmaceutical Material, the quick ratio is 9.86, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Jiangsu Hualan New Pharmaceutical Material? The latest ROE figure is 2.22%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Jiangsu Hualan New Pharmaceutical Material, the total asset return on investment (ROA) is 2.02%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Jiangsu Hualan New Pharmaceutical Material's latest financial report to see how their gross margin is doing - currently at 39.15%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Jiangsu Hualan New Pharmaceutical Material, the net profit margin is 12.36%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
